Patents by Inventor Franca Ronchese

Franca Ronchese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9764037
    Abstract: The invention relates to sphingoglycolipid analogs and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: September 19, 2017
    Assignee: Victoria Link Limited
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Franca Ronchese
  • Publication number: 20150352219
    Abstract: The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Application
    Filed: December 6, 2013
    Publication date: December 10, 2015
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Franca Ronchese
  • Patent number: 6900024
    Abstract: The present invention concerns TCR ligands with immunomodulatory properties, as well as methods of identifying such ligands and of using such ligands to modulate T cell effector responses.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: May 31, 2005
    Assignee: The United States of America as represented by the Secretary of the Department of Health & Human Services
    Inventors: Ronald N. Germain, Luigi Racioppi, Franca Ronchese-Le Gros
  • Publication number: 20030077286
    Abstract: The present invention concerns TCR ligands with immunomodulatory properties, as well as methods of identifying such ligands and of using such ligands to modulate T cell effector responses.
    Type: Application
    Filed: July 10, 2002
    Publication date: April 24, 2003
    Inventors: Ronald N. Germain, Luigi Racioppi, Franca Ronchese-Le Gros
  • Publication number: 20010016198
    Abstract: The present invention concerns TCR ligands with immunomodulatory properties, as well as methods of identifying such ligands and of using such ligands to modulate T cell effector responses.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 23, 2001
    Inventors: Ronald N. Germain, Luigi Racioppi, Franca Ronchese-Le Gros
  • Publication number: 20010006792
    Abstract: The present invention concerns TCR ligands with immunomodulatory properties, as well as methods of identifying such ligands and of using such ligands to modulate T cell effector responses.
    Type: Application
    Filed: February 2, 2001
    Publication date: July 5, 2001
    Inventors: Ronald N. Germain, Luigi Racioppi, Franca Ronchese-Le Gros
  • Patent number: 5837477
    Abstract: The present invention concerns TCR ligands with immunomodulatory properties, as well as methods of identifying such ligands and of using such ligands to modulate T cell effector responses.
    Type: Grant
    Filed: January 15, 1993
    Date of Patent: November 17, 1998
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Ronald N. Germain, Luigi Racioppi, Franca Ronchese-Le Gros